CareTrust Buys the Developer, Not Just the Buildings
The Quarter That Should Have Moved the Stock
CareTrust REIT reported the kind of quarter most REITs would trade up on: normalized FFO per share up 20%, $2.9 billion invested year-to-date across three growth engines, guidance raised, and lease coverage at record levels. Yet the stock was flat on the call and sits 12% below its July peak. The analyst question cut to the chase.
You guys put up massive numbers, 20% earnings growth, great rent coverage, everything is going in the right direction, but yet you have flat stock performance this morning. And I think the key question everyone's asking is how sustainable is this going forward.
That is the tension in this report. The operating story is accelerating; the equity story is waiting on the cost of capital. CareTrust's own growth story has become a rates story, and management knows it. “Normalized FFO per share is up 20% over last year. And year-to-date, we've set another record of approximately $2.9 billion invested across all 3 growth engines, setting up 2027 to be another strong year of growth.” — David Sedgwick, Chief Executive Officer · 2026-11-06 The market heard the first sentence and marked the second to the 10-year.
LNT Is the Real Change
The headline number is not the most important new fact. The LNT deal is. CareTrust is buying 45 newly developed U.K. care homes from Lawrence Tomlinson's LNT, with the first 23 closing for about $733 million, and a structure that starts as triple-net and is expected to convert to RIDEA/SHOP as homes stabilize. On conversion, management guides to a high-7% yield on in-place EBITDA, with room to low-8s and a path to double-digit unlevered returns. That is a different animal from the marketed U.S. SHOP auctions CareTrust has been losing on price.
The strategic pivot is subtle but real. In February, Derek Bunker was explicit that U.S. development did not pencil: “right now, generally, you know, it still does not pencil to do anything in a significant way here in the United States with respect to development.” — Michael Goldsmith, Analyst · 2026-02-13 In May, asked about applying RIDEA to the U.K., David Sedgwick said: “I think there will be a time when that opportunity presents itself for us, and we should be ready to do that.” — David M. Sedgwick, President and CEO · 2026-05-08 Six months later, the company has engineered exactly that — but through a developer relationship rather than a one-off asset purchase. The bespoke structure is designed to solve the traditional REIT problem of buying brand-new assets during lease-up. As Sedgwick put it, “we traded 2 years of growth for downside protection while retaining 28-plus years of upside.” — David Sedgwick, Chief Executive Officer · 2026-11-06
The product detail matters. LNT builds standardized homes with 100% ensuite wet rooms at roughly GBP 100,000 per unit less than typical U.K. development, targeting private-pay residents about 10%–15% below luxury RevPOR. That is a cost and positioning advantage, not just a cap-rate story. If it works, CareTrust gets a U.K. SHOP pipeline of 150-plus sites and potentially the developer itself; if lease-up slips, the triple-net phase protects near-term rent.
What Changed in SHOP — and What Management Stopped Saying
For several quarters, CareTrust's SHOP message was disciplined patience. In August, James Callister said the company would not stretch: “we don't feel a huge compulsion to have to stretch to do a deal that doesn't make sense for us.” — James Callister, President · 2026-08-07 David Sedgwick added that CareTrust had the luxury of being opportunistic across all three engines, unlike peers who had pivoted and gone all in on SHOP. The new call keeps the discipline language but changes the posture. U.S. SHOP is now described as a real near-term pipeline, with about $400 million closed in the first year and Sedgwick saying he would be really surprised if next year wasn't quite a bit more. The LNT deal adds a U.K. SHOP engine that did not exist before. That is a meaningful shift from 'we don't have to do SHOP' to 'we now have a differentiated way to do SHOP.'
What management notably did not do is put a SHOP percentage target in front of investors. Asked directly, Sedgwick refused to box the company in. That is consistent with prior calls, but it also means the market has to underwrite a strategy rather than a number. The keyword trail shows the change: U.K. care and care home are now top-of-mind, and the old SHOP patience language has been replaced by SHOP pipeline language. The story has moved from buying assets to buying a development capability.
The Balance Sheet Is the Insurance Policy
The reason this pivot is credible rather than reckless is the balance sheet. CareTrust closed a new $700 million unsecured term loan maturing in 2032 and upsized its revolver to $2 billion. At quarter-end, net debt to annualized normalized run-rate EBITDA was 1.4x; pro forma for year-to-date investments, about 2.7x, still below the 4x–5x target range. “Net debt to annualized normalized run rate EBITDA was 1.4x at quarter end. Pro forma, including all investments year-to-date, it's approximately 2.7x, still well below the low end of our long-term target range of 4x to 5x.” — Derek Bunker, Chief Financial Officer · 2026-11-06 The last filed quarter showed the same conservatism: liabilities were just 23.9% of assets, and net income rose 30% year over year to $89 million.
That gives management an option most REITs do not have: fund the pipeline without immediately tapping equity. Derek Bunker framed the no-capital-markets path as a fallback: “I think it was a little more of the latter, thought exercise. And I think we view that as a fallback and a sort of Plan C.” — Derek Bunker, Chief Financial Officer · 2026-11-06 The market, however, is focused on the cost of that capital. With interest rates moving against REITs this fall, a 20% FFO grower trading at 26.8x trailing net income can still drift lower. The stock's 12% drawdown from its July peak is not a verdict on the LNT deal; it is a verdict on the discount rate applied to all REIT growth.
The bull case is that CareTrust is using its low leverage to buy growth while rivals are capital-constrained, and that LNT converts into a multiyear, differentiated SHOP engine. The bear case is that the market will not pay for that growth until rates stabilize or the company proves the LNT lease-up math. Sedgwick's closing answer to the sustainability question was designed for exactly that debate: “unlike when I had to answer that question in '24, when this growth story really started kicking in, I don't have the timidity as I look forward in the near-to-mid term.” — David Sedgwick, Chief Executive Officer · 2026-11-06 After this quarter, the burden of proof has shifted from the income statement to the stock price — and to whether the LNT flywheel spins as advertised.